Phase II trial of trimetrexate in the treatment of recurrent childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Pappo
A
A
University of Texas, Southwestern Medical Center, Dallas 75235-9063.
Dubowy
R
R
Ravindranath
Y
Y
Alvarado
C
C
Rao
S
S
Whitehead
V M
VM
Vega
R
R
Kamen
B
B
Vietti
T
T
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007223:Infant; D007262:Infusions, Intravenous; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D011799:Quinazolines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012008:Recurrence; D012074:Remission Induction; D016597:Trimetrexate
D011799:Quinazolines; D016597:Trimetrexate